IRCT2016030126857N1已完成4 期
Sublingual misoprostol to reduce blood loss at cesarean delivery
Vice President of Research of mashhad university of medical science0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •inclusion criteria: the term pregnant women with risk factor for post partum hemorrhage such as uterine overdistention (multifetal gestatation.macrosomia), arrest disorder, prolonged induction and prolonged preterm rupture of membrane
- •exclusion criteria: Lack of consent, coagulation disorders , Anemia, Intraabdominal adhesion, Intraoperative bladder and intestines and other viscera damage, Abnormal adhesion of placenta, extended Uterine incision during cesarean delivery and known hypersensitivity to misoprostol.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Sublingual Misoprostol to Reduce Blood Loss in Cesarean DeliveryCesarean Section.Single delivery by cesarean sectionIRCT2016041125648N3Vice Chancellor for Research of Mashhad University of Medical Sciences90
已完成
4 期
A study on pre-operative Misoprostol in reducing blood loss in total abdominal hysterectomyCTRI/2011/091/000216one50
已完成
不适用
The use of misoprostol suppositories to reduce radiotherapy-induced anorectal dysfunctioAcute radiation proctitisDigestive SystemOther diseases of anus and rectumISRCTN17865479Department of Health (UK)50
Unknown
2 期
Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean DeliveryHemorrhage PostpartumNCT03140033Ain Shams Maternity Hospital158
招募中
2 期
Effect of rectal Misoprostol in reducing blood loss before hysterectomy and myomectomyterine lymphoma.benign neoplasms of uterus with morphology code M889 and behaviour code /0 fibromyoma of uterusIRCT20181020041394N1Babol University of Medical Sciences80